NEW YORK (GenomeWeb News) – Active Motif announced Thursday that it has acquired privately held genomics tools maker SwitchGear Genomics for an undisclosed price.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SwitchGear Genomics today said it has partnered with New England Biolabs to develop a new dual reporter assay system.
Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear.
BioCat will distribute the firm's LightSwitch Luciferase Assay System in select European countries.
Under the distribution agreement, SwitchGear will offer the reagent as a standalone product as well as part of its own LightSwitch Transfection Optimization kit.
The collaboration brings together SwitchGear's expertise in gene regulatory networks and Sigma-Aldrich's lentiviral technology and is expected to result in a genome-wide collection of target vectors.
The method combines Promega's HaloCHIP DNA-protein complex capture technology and SwitchGear's high-throughput promoter assays.
Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.
The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.
US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.
In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.